Farringdon Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,341
Closed -$650K 606
2025
Q1
$650K Buy
+1,341
New +$650K 0.33% 72